The long Avandia endgame.
Lancet. 2011 Jul 9; 378 (9786): 113.
Sidelining safety--the FDA's inadequate response to the IOM.
N. Engl. J. Med. 2007 Sep 6;357(10):960-3.
Congress responds to the IOM drug safety report--in full.
JAMA. 2007 Nov 14; 298 (18): 2185-7.